Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p><it>Staphylococcus aureus</it> bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, <it>S. aureus</it> can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Thwaites Guy, Auckland Cressida, Barlow Gavin, Cunningham Richard, Davies Gerry, Edgeworth Jonathan, Greig Julia, Hopkins Susan, Jeyaratnam Dakshika, Jenkins Neil, Llewelyn Martin, Meisner Sarah, Nsutebu Emmanuel, Planche Tim, Read Robert C, Scarborough Matthew, Soares Marta, Tilley Robert, Török M Estée, Williams John, Wilson Peter, Wyllie Sarah, Walker A Sarah
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2012-12-01
Colecção:	Trials
Assuntos:	<it>Staphylococcus aureus</it> Bacteraemia Rifampicin Mortality
Acesso em linha:	http://www.trialsjournal.com/content/13/1/241
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!